Aytu Biopharma, Inc. (AYTU)
2.30
-0.01
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
2.33
+0.03
(+1.30%)
After-Hours: 20:00
Aytu Biopharma Shareholders Equity (Quarterly) : 14.20M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Altimmune, Inc. | 185.60M |
| Actinium Pharmaceuticals, Inc. | 13.78M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Annovis Bio, Inc. | 13.16M |
| BioAtla, Inc. | -31.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Total Liabilities (Quarterly) | 107.80M |
| Debt to Equity Ratio | 1.556 |
| Current Ratio | 1.163 |
| Net Debt Paydown Yield | -2.81% |